The past, present and future of renin-angiotensin aldosterone system inhibition

被引：92
|
作者：
Mentz, Robert J. [1 ]
Bakris, George L. [2 ]
Waeber, Bernard [3 ,4 ]
McMurray, John J. V. [5 ]
Gheorghiade, Mihai [6 ]
Ruilope, Luis M. [7 ]
Maggioni, Aldo P. [8 ]
Swedberg, Karl [9 ]
Pina, Ileana L. [10 ]
Fiuzat, Mona [1 ]
O'Connor, Christopher M. [1 ]
Zannad, Faiez [11 ]
Pitt, Bertram [12 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
[2] Univ Chicago Med, Chicago, IL USA
[3] CHU Vaudois, Lausanne, Switzerland
[4] Univ Lausanne, Lausanne, Switzerland
[5] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[6] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA
[7] Hosp 12 Octubre, E-28041 Madrid, Spain
[8] Assoc Nazl Med Cardiol Osped Res Ctr, Florence, Italy
[9] Univ Gothenburg, Gothenburg, Sweden
[10] Montefiore Einstein Med Ctr, New York, NY USA
[11] Ctr Invest Clin, Nancy, France
[12] Univ Michigan, Sch Med, Univ Hosp, Ann Arbor, MI USA
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 05期
关键词：
Renin-angiotensin aldosterone system; Hypertension; Heart failure; Myocardial infarction; Clinical trials; CONVERTING-ENZYME-INHIBITORS; CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; MINERALOCORTICOID RECEPTOR ACTIVATION; HIGH-RISK PATIENTS; ATRIAL-FIBRILLATION; DOUBLE-BLIND; RANDOMIZED-TRIAL; II-RECEPTOR;
D O I：
10.1016/j.ijcard.2012.10.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The renin-angiotensin aldosterone system (RAAS) is central to the pathogenesis of cardiovascular disease. RAAS inhibition can reduce blood pressure, prevent target organ damage in hypertension and diabetes, and improve outcomes in patients with heart failure and/or myocardial infarction. This review presents the history of RAAS inhibition including a summary of key heart failure, myocardial infarction, hypertension and atrial fibrillation trials. Recent developments in RAAS inhibition are discussed including implementation and optimization of current drug therapies. Finally, ongoing clinical trials, opportunities for future trials and issues related to the barriers and approvability of novel RAAS inhibitors are highlighted. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：1677 / 1687
页数：11
相关论文
共 50 条
  • [31] Combinations of Renin-Angiotensin-Aldosterone System Antagonists: True Advantages?
    Veglio, Franco
    Puglisi, Elisabetta
    Milan, Alberto
    Mulatero, Paolo
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (07) : 952 - 957
  • [32] Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension
    Doulton, Timothy W. R.
    MacGregor, Graham A.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2009, 10 (04) : 185 - 189
  • [33] Dual Renin-Angiotensin-Aldosterone Blockade: Promises and Pitfalls
    Chrysant, Steven G.
    Chrysant, George S.
    CURRENT HYPERTENSION REPORTS, 2015, 17 (01) : 1 - 10
  • [34] Inhibiting the renin-angiotensin system: Why and in which patients
    Berra, Kathy
    Miller, Nancy Houston
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2009, 21 (01): : 66 - 75
  • [35] Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events
    Papademetriou, Vasilios
    AMERICAN HEART JOURNAL, 2009, 157 (06) : S24 - S30
  • [36] Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?
    Mallat, Samir G.
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [37] New Advances in Blockade of the Renin-Angiotensin System - the Role of Direct Renin Inhibition
    Clark, Louise F.
    Rushworth, Gordon F.
    Leslie, Stephen J.
    MacRury, Sandra
    CURRENT HYPERTENSION REVIEWS, 2010, 6 (04) : 222 - 231
  • [38] Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19
    Loader, Jordan
    Lampa, Erik
    Gustafsson, Stefan
    Cars, Thomas
    Sundstrom, Johan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (15):
  • [39] Inflammation and Atherosclerosis: The Role of Renin-Angiotensin System and Its Inhibition
    Partigulova, A. S.
    Naumov, V. G.
    KARDIOLOGIYA, 2010, 50 (10) : 50 - 55
  • [40] Modulation of the Renin-Angiotensin-Aldosterone System in Heart Failure
    George, J.
    Struthers, A. D.
    Lang, C. C.
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (04)
12345